Population Diagnostics, Inc. Company Profile
Population Diagnostics, Inc. (PDx, www.populationdiagnostics.com) is applying its discoveries in human genetics to the development of DNA-based diagnostics and personalized medicine tests. PDxâs technology, which reveals the genetic causes of complex diseases such as autism, diabetes, Parkinsonâs, and Alzheimerâs, enables development of early detection diagnostic tests that predict pre-symptomatically why some individuals will suffer from debilitating diseases while others will not. When applied to drug discovery, the technology enables pharmaceutical companies to develop targeted therapies and companion diagnostics. Its novel technology and exclusive products places PDx in a prime position to (i) transform how physicians diagnose and manage disease in their patients and (ii) enable pharmaceutical companies to expand the number of available therapies and market drugs with higher efficacy and safety.
News Articles
Population Diagnostics Aids Identification of Autism CNVs
Bio-IT World | A small biotech company, Population Diagnostics (PDx), has collaborated with researchers at The Hospital for Sick Children in Toronto (SickKids) to provide a potentially major step...
Miami’s ERBA Diagnostics, Inc. Acquires Escalon Medical Corp. Clinical Diagnostics Business
ERBA Diagnostics, a fully integrated in vitro diagnostics company, has acquired from Escalon Medical Corp. its Clinical Diagnostics Business for $6.5 million in cash. Revenues from the Escalon Clinica...
ERBA Diagnostics to showcase full range of products at AACC annual meeting
ERBA Diagnostics, Inc., a fully integrated in vitro diagnostics company, is pleased to announce that Suresh Vazirani, Chairman of ERBA Diagnostics, will be a key note speaker at the International Mark...
PrimeraDx, Quest Diagnostics to develop companion diagnostics
PrimeraDx, a molecular diagnostics company, has formed a non-exclusive diagnostics co-development agreement with Quest Diagnostics, a diagnostics information services company. The intent of the collab...
SQI Diagnostics reports net loss of $1,563,000 for quarter-ended December 31, 2012
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial...
Pathwork Diagnostics names Lee McCracken as new CEO
Pathwork Diagnostics, a developer of oncology diagnostics assays, has named Lee McCracken as the company's new chief executive officer (CEO).
Aurora Diagnostics Cancels Plans for an IPO
Aurora Diagnostics, a specialized diagnostics company focusing on the anatomic pathology market, canceled its long-delayed plans for an...
IVAX Diagnostics first quarter net revenues increase 3.4% to $4,273,000
IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the quarter ended March 31, 2012.
Drugs and Medications
Oxygen [A.M. Home Diagnostics Inc. dba Healthline]
Oxygen
Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]
CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%
Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]
CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%
Multihance [Bracco Diagnostics Inc]
These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...
Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]
RENO-30 Diatrizoate Meglumine Injection USP 30%
PubMed Articles
PURPOSE: A framework for the evaluation of paediatric population models is proposed and applied to two different paediatric population pharmacokinetic models for morphine. One covariate model was base...
Microfluidic diagnostics for the developing world.
For more than a decade, it has been expected that microfluidic technology would revolutionize the healthcare industry with simple, inexpensive, effective, and ubiquitous miniature diagnostic devices....
The diagnosis of latent and active tuberculosis in the HIV-positive population is challenged by diminished sensitivity of conventional tests, atypical presentations, and the lack of culture methods in...
Platform Technologies for Molecular Diagnostics near the Patient's Bedside.
: It is believed Lab-on-Chip systems will become a mainstream technology within the next centuries. Especially because of new findings in molecular medicine and global trends such as the changing gl...
Exploring the possibility of early cataract diagnostics based on tryptophan fluorescence.
A novel route for early cataract diagnostics is investigated based on the excitation of tryptophan fluorescence (TF) at the red edge of its absorption band at 317 nm. This allows penetration through t...
Clinical Trials
BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes
Pacemaker technology is constantly evolving. In the past 10 years, numerous advancements have been made in pacemaker therapy, diagnostics and connectivity. These advancements include autom...
Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test
This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of...
Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer
Quality of Life-Diagnostics and -Therapy in Individual Patients with Breast Cancer. A randomized study including 200 patients, 5 clinics and 43 general practitioners as coordinating docto...
Implementation of Quality of Life Diagnostics and Therapy
Implementation and Evaluation of Implementation of Quality of Life Diagnostics and Therapy in Individual Patients with Breast Cancer. A prospective study including 170 patients, 5 clinics...
Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population
This study is to establish the clinical sensitivity of the Chembio Diagnostics Systems, Inc. Clearview COMPLETE HIV 1/2 Assay and Clearview HIV 1/2 Stat-Pak Assay (Clearview HIV tests) in...
Companies
Veterinary Diagnostics Institute (VDxI), Inc.
VDxI, a California corporation, is a veterinary clinical ventures company dedicated to the introduction of innovative biomarkers for companion animals. Through collaboration with...
Population Diagnostics, Inc. (PDx, www.populationdiagnostics.com) is applying its discoveries in human genetics to the development of DNA-based diagnostics and personalized medici...
Quintiles and Population Genetics Technologies Ltd.
Co-founded by Nobel Laureate Dr. Sydney Brenner, Population Genetics Technologies creates products that accelerate large-scale population studies, through the simultaneous analysi...
A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices...
Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac...
More Information about "Population Diagnostics, Inc." on BioPortfolio
We have published hundreds of Population Diagnostics, Inc. news stories on BioPortfolio along with dozens of Population Diagnostics, Inc. Clinical Trials and PubMed Articles about Population Diagnostics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Population Diagnostics, Inc. Companies in our database. You can also find out about relevant Population Diagnostics, Inc. Drugs and Medications on this site too.
